Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 140196, 13 pages
http://dx.doi.org/10.1155/2015/140196
Review Article

The Role of Ovarian Sex Steroids in Metabolic Homeostasis, Obesity, and Postmenopausal Breast Cancer: Molecular Mechanisms and Therapeutic Implications

1Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn University, 154 Rama I Road Patumwan, Bangkok 10330, Thailand
2Graduate Program in Clinical Biochemistry and Molecular Medicine, Thailand

Received 31 July 2014; Accepted 6 October 2014

Academic Editor: Eileen M. McGowan

Copyright © 2015 Viroj Boonyaratanakornkit and Prangwan Pateetin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Kelly, W. Yang, C.-S. Chen, K. Reynolds, and J. He, “Global burden of obesity in 2005 and projections to 2030,” International Journal of Obesity, vol. 32, no. 9, pp. 1431–1437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. C. Wang, K. McPherson, T. Marsh, S. L. Gortmaker, and M. Brown, “Health and economic burden of the projected obesity trends in the USA and the UK,” The Lancet, vol. 378, no. 9793, pp. 815–825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. K. Masters, E. N. Reither, D. A. Powers, Y. C. Yang, A. E. Burger, and B. G. Link, “The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates,” American Journal of Public Health, vol. 103, no. 10, pp. 1895–1901, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. E. E. Calle and R. Kaaks, “Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms,” Nature Reviews Cancer, vol. 4, no. 8, pp. 579–591, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. G. Renehan, M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen, “Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies,” The Lancet, vol. 371, no. 9612, pp. 569–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Protani, M. Coory, and J. H. Martin, “Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis,” Breast Cancer Research and Treatment, vol. 123, no. 3, pp. 627–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Zeleniuch-Jacquotte, R. E. Shore, K. L. Koenig et al., “Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study,” British Journal of Cancer, vol. 90, no. 1, pp. 153–159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. J. Key, P. N. Appleby, G. K. Reeves et al., “Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women,” Journal of the National Cancer Institute, vol. 95, no. 16, pp. 1218–1226, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Tretli, T. Haldorsen, and L. Ottestad, “The effect of pre-morbid height and weight on the survival of breast cancer patients,” British Journal of Cancer, vol. 62, no. 2, pp. 299–303, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Rosato, C. Bosetti, R. Talamini et al., “Metabolic syndrome and the risk of breast cancer in postmenopausal women,” Annals of Oncology, vol. 22, no. 12, pp. 2687–2692, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. K. Glass and J. M. Olefsky, “Inflammation and lipid signaling in the etiology of insulin resistance,” Cell Metabolism, vol. 15, no. 5, pp. 635–645, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. R. Simpson and K. A. Brown, “Minireview: obesity and breast cancer: a tale of inflammation and dysregulated metabolism,” Molecular Endocrinology, vol. 27, no. 5, pp. 715–725, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. R. A. Cairns, I. S. Harris, and T. W. Mak, “Regulation of cancer cell metabolism,” Nature Reviews Cancer, vol. 11, no. 2, pp. 85–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Basu, R. Nachat-Kappes, F. Caldefie-Chézet, and M.-P. Vasson, “Eicosanoids and adipokines in breast cancer: from molecular mechanisms to clinical considerations,” Antioxidants & Redox Signaling, vol. 18, no. 3, pp. 323–360, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Publisher · View at Google Scholar · View at Scopus
  17. P. P. Hsu and D. M. Sabatini, “Cancer cell metabolism: warburg and beyond,” Cell, vol. 134, no. 5, pp. 703–707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Mazurek, “Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells,” The International Journal of Biochemistry & Cell Biology, vol. 43, no. 7, pp. 969–980, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H. R. Christofk, M. G. Vander Heiden, M. H. Harris et al., “The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth,” Nature, vol. 452, no. 7184, pp. 230–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. D. Giles, E. A. Wellberg, D. P. Astling et al., “Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer,” Cancer Research, vol. 72, no. 24, pp. 6490–6501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. S. MacLean, E. D. Giles, G. C. Johnson et al., “A surprising link between the energetics of ovariectomy-induced weight gain and mammary tumor progression in obese rats,” Obesity, vol. 18, no. 4, pp. 696–703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. A. Salama, M. A. Mohammad, C. R. Diaz-Arrastia et al., “Estradiol-17β upregulates Pyruvate kinase M2 expression to co-activate estrogen receptor-α and to integrate metabolic reprogramming with the mitogenic response in endometrial cells,” The Journal of Clinical Endocrinology Metabolism, vol. 99, no. 10, pp. 3790–3799, 2014. View at Google Scholar
  23. M. J. Khandekar, P. Cohen, and B. M. Spiegelman, “Molecular mechanisms of cancer development in obesity,” Nature Reviews Cancer, vol. 11, no. 12, pp. 886–895, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Zhao, V. R. Agarwal, C. R. Mendelson, and E. R. Simpson, “Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene,” Endocrinology, vol. 137, no. 12, pp. 5739–5742, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. S. R. Salpeter, J. M. E. Walsh, T. M. Ormiston, E. Greyber, N. S. Buckley, and E. E. Salpeter, “Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women,” Diabetes, Obesity and Metabolism, vol. 8, no. 5, pp. 538–554, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. B. Ropero, P. Alonso-Magdalena, I. Quesada, and A. Nadal, “The role of estrogen receptors in the control of energy and glucose homeostasis,” Steroids, vol. 73, no. 9-10, pp. 874–879, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Ohlsson, N. Hellberg, P. Parini et al., “Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice,” Biochemical and Biophysical Research Communications, vol. 278, no. 3, pp. 640–645, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. P. A. Heine, J. A. Taylor, G. A. Iwamoto, D. B. Lubahn, and P. S. Cooke, “Increased adipose tissue in male and female estrogen receptor-α knockout mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 23, pp. 12729–12734, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Morishima, M. M. Grumbach, E. R. Simpson, C. Fisher, and K. Qin, “Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens,” The Journal of Clinical Endocrinology & Metabolism, vol. 80, no. 12, pp. 3689–3698, 1995. View at Google Scholar · View at Scopus
  30. E. P. Smith, J. Boyd, G. R. Frank et al., “Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man,” The New England Journal of Medicine, vol. 331, no. 16, pp. 1056–1061, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Bryzgalova, H. Gao, B. Ahren et al., “Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver,” Diabetologia, vol. 49, no. 3, pp. 588–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Ribas, B. G. Drew, J. A. Le et al., “Myeloid-specific estrogen receptor α deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 39, pp. 16457–16462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Zhu, W. C. Brown, Q. Cai et al., “Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance,” Diabetes, vol. 62, no. 2, pp. 424–434, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Gao, G. Mezei, Y. Nie et al., “Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals,” Nature Medicine, vol. 13, no. 1, pp. 89–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Yonezawa, T. Wada, N. Matsumoto et al., “Central versus peripheral impact of estradiol on the impaired glucose metabolism in ovariectomized mice on a high-fat diet,” American Journal of Physiology: Endocrinology and Metabolism, vol. 303, no. 4, pp. E445–E456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Moreno, P. Ordoñez, A. Alonso, F. Díaz, J. Tolivia, and C. González, “Chronic 17β-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging,” Age, vol. 32, no. 1, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. R. P. A. Barros and J.-Å. Gustafsson, “Estrogen receptors and the metabolic network,” Cell Metabolism, vol. 14, no. 3, pp. 289–299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. M. D'Eon, S. C. Souza, M. Aronovitz, M. S. Obin, S. K. Fried, and A. S. Greenberg, “Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways,” Journal of Biological Chemistry, vol. 280, no. 43, pp. 35983–35991, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. J.-Q. Chen, T. R. Brown, and J. Russo, “Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1793, no. 7, pp. 1128–1143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Furman, E. Rushkin, R. Margalit, P. Bendel, and H. Degani, “Tamoxifen induced changes in MCF7 human breast cancer: In vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 43, no. 1–3, pp. 189–195, 1992. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Kostanyan and K. Nazaryan, “Rat brain glycolysis regulation by estradiol-17β,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1133, no. 3, pp. 301–306, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Pastorelli, D. Carpi, L. Airoldi et al., “Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone,” Proteomics, vol. 5, no. 18, pp. 4936–4945, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Beckett, A. Tchernof, and M. J. Toth, “Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats,” Metabolism: Clinical and Experimental, vol. 51, no. 11, pp. 1397–1401, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Stirone, S. P. Duckles, D. N. Krause, and V. Procaccio, “Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels,” Molecular Pharmacology, vol. 68, no. 4, pp. 959–965, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Nilsen, R. W. Irwin, T. K. Gallaher, and R. D. Brinton, “Estradiol in vivo regulation of brain mitochondrial proteome,” The Journal of Neuroscience, vol. 27, no. 51, pp. 14069–14077, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. S.-H. Yang, R. Liu, E. J. Perez et al., “Mitochondrial localization of estrogen receptor β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 4130–4135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. T. A. Milner, K. Ayoola, C. T. Drake et al., “Ultrastructural localization of estrogen receptor β immunoreactivity in the rat hippocampal formation,” Journal of Comparative Neurology, vol. 491, no. 2, pp. 81–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Q. Chen, M. Eshete, W. L. Alworth, and J. D. Yager, “Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors α and β to human mitochondrial DNA estrogen response elements,” Journal of Cellular Biochemistry, vol. 93, no. 2, pp. 358–373, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Pedram, M. Razandi, D. C. Wallace, and E. R. Levin, “Functional estrogen receptors in the mitochondria of breast cancer cells,” Molecular Biology of the Cell, vol. 17, no. 5, pp. 2125–2137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Solakidi, A.-M. G. Psarra, and C. E. Sekeris, “Differential subcellular distribution of estrogen receptor isoforms: localization of ERα in the nucleoli and ERβ in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1745, no. 3, pp. 382–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. C. M. van Itallie and P. S. Dannies, “Estrogen induces accumulation of the mitochondrial ribonucleic acid for subunit II of cytochrome oxidase in pituitary tumor cells,” Molecular Endocrinology, vol. 2, no. 4, pp. 332–337, 1988. View at Publisher · View at Google Scholar · View at Scopus
  52. J.-Q. Chen, P. A. Russo, C. Cooke, I. H. Russo, and J. Russo, “ERβ shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1773, no. 12, pp. 1732–1746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. R. D. Brinton, “Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease,” Advanced Drug Delivery Reviews, vol. 60, no. 13-14, pp. 1504–1511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Toda, K. Takeda, S. Akira et al., “Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice and their reversal by the treatment with 17β-estradiol or a peroxisome proliferator,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 79, no. 1–5, pp. 11–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Kamei, M. Suzuki, H. Miyazaki et al., “Ovariectomy in mice decreases lipid metabolism-related gene expression in adipose tissue and skeletal muscle with increased body fat,” Journal of Nutritional Science and Vitaminology, vol. 51, no. 2, pp. 110–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. J. R. Rettberg, J. Yao, and R. D. Brinton, “Estrogen: a master regulator of bioenergetic systems in the brain and body,” Frontiers in Neuroendocrinology, vol. 35, no. 1, pp. 8–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Zhou and L. Rui, “Leptin signaling and leptin resistance,” Frontiers of Medicine, vol. 7, no. 2, pp. 207–222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. L. M. Brown, L. Gent, K. Davis, and D. J. Clegg, “Metabolic impact of sex hormones on obesity,” Brain Research, vol. 1350, pp. 77–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. S. C. Hong, S. W. Yoo, G. J. Cho et al., “Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women,” Menopause, vol. 14, no. 5, pp. 835–840, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. A. J. G. Hanley, D. Bowden, L. E. Wagenknecht et al., “Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 7, pp. 2665–2671, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. N. J. Tomicek, T. S. Lancaster, and D. H. Korzick, “Increased estrogen receptor β in adipose tissue is associated with increased intracellular and reduced circulating adiponectin protein levels in aged female rats,” Gender Medicine, vol. 8, no. 5, pp. 325–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Foryst-Ludwig, M. Clemenz, S. Hohmann et al., “Metabolic actions of estrogen receptor beta (ERβ) are mediated by a negative cross-talk with PPARγ,” PLoS Genetics, vol. 4, no. 6, Article ID e1000108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. V. Boonyaratanakornkit, “Mechanisms of estrogen receptor extranuclear signaling in human diseases,” in Estrogen Receptors: Mechanisms, Structure and Role in Diseases, G. Chen, Ed., pp. 11–28, Nova Science Publishers, New York, NY, USA, 2012. View at Google Scholar
  64. M. Beato and J. Klug, “Steroid hormone receptors: an update,” Human Reproduction Update, vol. 6, no. 3, pp. 225–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Tora, J. White, C. Brou et al., “The human estrogen receptor has two independent nonacidic transcriptional activation functions,” Cell, vol. 59, no. 3, pp. 477–487, 1989. View at Publisher · View at Google Scholar · View at Scopus
  66. V. Boonyaratanakornkit, “Scaffolding proteins mediating membrane-initiated extra-nuclear actions of estrogen receptor,” Steroids, vol. 76, no. 9, pp. 877–884, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. V. Boonyaratanakornkit and D. P. Edwards, “Receptor mechanisms mediating non-genomic actions of sex steroids,” Seminars in Reproductive Medicine, vol. 25, no. 3, pp. 139–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Handgraaf, E. Riant, A. Fabre et al., “Prevention of obesity and insulin resistance by estrogens requires ERα activation function-2 (ERαAF-2), whereas ERαAF-1 is dispensable,” Diabetes, vol. 62, no. 12, pp. 4098–4108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. C. J. Park, Z. Zhao, C. Glidewell-Kenney et al., “Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice,” The Journal of Clinical Investigation, vol. 121, no. 2, pp. 604–612, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Fujita, Y. Kobayashi, O. Wada et al., “Full activation of estrogen receptor α activation function-1 induces proliferation of breast cancer cells,” Journal of Biological Chemistry, vol. 278, no. 29, pp. 26704–26714, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Wada, H. Tsuneki, and T. Sasaoka, “New insights into metabolic regulation via bifurcated function of estrogen receptor a,” Diabetes, vol. 62, no. 12, pp. 3996–3998, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. P. Kastner, A. Krust, B. Turcotte et al., “Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B,” EMBO Journal, vol. 9, no. 5, pp. 1603–1614, 1990. View at Google Scholar · View at Scopus
  73. K. M. Scarpin, J. D. Graham, P. A. Mote, and C. L. Clarke, “Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression,” Nuclear Receptor Signaling, vol. 7, article e009, 2009. View at Google Scholar · View at Scopus
  74. B. Mulac-Jericevic, R. A. Mullinax, F. J. DeMayo, J. P. Lydon, and O. M. Conneely, “Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform,” Science, vol. 289, no. 5485, pp. 1751–1754, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Mulac-Jericevic, J. P. Lydon, F. J. DeMayo, and O. M. Conneely, “Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 17, pp. 9744–9749, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. V. Boonyaratanakornkit, M. P. Scott, V. Ribon et al., “Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases,” Molecular Cell, vol. 8, no. 2, pp. 269–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. R. P. Carnevale, C. J. Proietti, M. Salatino et al., “Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways,” Molecular Endocrinology, vol. 21, no. 6, pp. 1335–1358, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. V. Boonyaratanakornkit, E. McGowan, L. Sherman, M. A. Mancini, B. J. Cheskis, and D. P. Edwards, “The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle,” Molecular Endocrinology, vol. 21, no. 2, pp. 359–375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz, “Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells,” Journal of Biological Chemistry, vol. 277, no. 7, pp. 5209–5218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. N. F. Butte, “Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus,” The American Journal of Clinical Nutrition, vol. 71, no. 5, pp. 1256s–1261s, 2000. View at Google Scholar · View at Scopus
  81. American Diabetes Association, “Gestational diabetes mellitus,” Diabetes Care, vol. 27, supplement 1, pp. S88–S90, 2004. View at Publisher · View at Google Scholar
  82. C. Gonzalez, A. Alonso, N. Alvarez et al., “Role of 17β-estradiol and/or progesterone on insulin sensitivity in the rat: Implications during pregnancy,” Journal of Endocrinology, vol. 166, no. 2, pp. 283–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. S. E. Campbell and M. A. Febbraio, “Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 282, no. 5, pp. E1139–E1146, 2002. View at Google Scholar · View at Scopus
  84. S. E. Campbell and M. A. Febbraio, “Effects of ovarian hormones on exercise metabolism,” Current Opinion in Clinical Nutrition & Metabolic Care, vol. 4, no. 6, pp. 515–520, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. I. R. Schlaepfer, C. A. Hitz, M. A. Gijón, B. C. Bergman, R. H. Eckel, and B. M. Jacobsen, “Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel,” Molecular and Cellular Endocrinology, vol. 363, no. 1-2, pp. 111–121, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. F. Picard, M. Wanatabe, K. Schoonjans, J. Lydon, B. W. O'Malley, and J. Auwerx, “Progesterone receptor knockout mice have an improved glucose homeostasis secondary to β-cell proliferation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15644–15648, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. R. Zhou, X. Yao, X. Xu et al., “Blockage of progesterone receptor effectively protects pancreatic islet beta cell viability,” Steroids, vol. 78, no. 10, pp. 987–995, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Gao, J. Mazella, M. Tang, and L. Tseng, “Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells,” Molecular Endocrinology, vol. 14, no. 12, pp. 1954–1961, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Gao and L. Tseng, “Progesterone receptor (PR) inhibits expression of insulin-like growth factor-binding protein-1 (IGFBP-1) in human endometrial cell line HEC-1B: characterization of the inhibitory effect of PR on the distal promoter region of the IGFP-1 gene,” Molecular Endocrinology, vol. 11, no. 7, pp. 973–979, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, Inflammation, and Cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. J. Yin, Z. Gao, Q. He, D. Zhou, Z. Guo, and J. Ye, “Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue,” American Journal of Physiology: Endocrinology and Metabolism, vol. 296, no. 2, pp. E333–E342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Wen, D. Gris, Y. Lei et al., “Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling,” Nature Immunology, vol. 12, no. 5, pp. 408–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Subbaramaiah, P. G. Morris, X. K. Zhou et al., “Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women,” Cancer Discovery, vol. 2, no. 4, pp. 356–365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. K. A. Brown and E. R. Simpson, “Obesity and breast cancer: progress to understanding the relationship,” Cancer Research, vol. 70, no. 1, pp. 4–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. S. E. Bulun, T. M. Price, J. Aitken, M. S. Mahendroo, and E. R. Simpson, “A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription,” The Journal of Clinical Endocrinology & Metabolism, vol. 77, no. 6, pp. 1622–1628, 1993. View at Google Scholar · View at Scopus
  96. J. S. O'Neill, R. A. Elton, and W. R. Miller, “Aromatase activity in adipose tissue from breast quadrants: a link with tumour site,” British Medical Journal, vol. 296, no. 6624, pp. 741–743, 1988. View at Publisher · View at Google Scholar · View at Scopus
  97. P. G. Morris, C. A. Hudis, D. Giri et al., “Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer,” Cancer Prevention Research, vol. 4, no. 7, pp. 1021–1029, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. S. C. Baumgarten and J. Frasor, “Minireview: inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers,” Molecular Endocrinology, vol. 26, no. 3, pp. 360–371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Nakshatri, P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet Jr., and G. W. Sledge Jr., “Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth,” Molecular and Cellular Biology, vol. 17, no. 7, pp. 3629–3639, 1997. View at Google Scholar · View at Scopus
  100. L. M. Morimoto, E. White, Z. Chen et al., “Obesity, body size, and risk of postmenopausal breast cancer: the women's health initiative (United States),” Cancer Causes and Control, vol. 13, no. 8, pp. 741–751, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. Y. Zhou, S. Eppenberger-Castori, C. Marx et al., “Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers,” The International Journal of Biochemistry & Cell Biology, vol. 37, no. 5, pp. 1130–1144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. J. Frasor, A. E. Weaver, M. Pradhan, and K. Mehta, “Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17β-estradiol and proinflammatory cytokines,” Endocrinology, vol. 149, no. 12, pp. 6272–6279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. S.-H. Chang, C. H. Liu, R. Conway et al., “Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 2, pp. 591–596, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. T. L. Larkins, M. Nowell, S. Singh, and G. L. Sanford, “Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression,” BMC Cancer, vol. 6, no. 1, article 181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  105. K.-J. Park, V. Krishnan, B. W. O'Malley, Y. Yamamoto, and R. B. Gaynor, “Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation,” Molecular Cell, vol. 18, no. 1, pp. 71–82, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. Z. Tu, S. Prajapati, K.-J. Park, N. J. Kelly, Y. Yamamoto, and R. B. Gaynor, “IKKα regulates estrogen-induced cell cycle progression by modulating E2F1 expression,” The Journal of Biological Chemistry, vol. 281, no. 10, pp. 6699–6706, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. R. H. Straub, “The complex role of estrogens in inflammation,” Endocrine Reviews, vol. 28, no. 5, pp. 521–574, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. D. Kalaitzidis and T. D. Gilmore, “Transcription factor cross-talk: The estrogen receptor and NF-κB,” Trends in Endocrinology & Metabolism, vol. 16, no. 2, pp. 46–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. K. W. Nettles, G. Gil, J. Nowak, R. Métivier, V. B. Sharma, and G. L. Greene, “CBP is a dosage-dependent regulator of nuclear factor-κB suppression by the estrogen receptor,” Molecular Endocrinology, vol. 22, no. 2, pp. 263–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. D. B. Hardy, B. A. Janowski, C.-C. Chen, and C. R. Mendelson, “Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms,” Molecular Endocrinology, vol. 22, no. 8, pp. 1812–1824, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Kobayashi, J. P. Stice, D. Kazmin et al., “Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer,” Molecular Endocrinology, vol. 24, no. 12, pp. 2292–2302, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. C. J. Creighton, C. Kent Osborne, M. J. van de Vijver et al., “Molecular profiles of progesterone receptor loss in human breast tumors,” Breast Cancer Research and Treatment, vol. 114, no. 2, pp. 287–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. M. D. Althuis, J. H. Fergenbaum, M. Garcia-Closas, L. A. Brinton, M. P. Madigan, and M. E. Sherman, “Etiology of hormone receptor-defined breast cancer: a systematic review of the literature,” Cancer Epidemiology, Biomarkers & Prevention, vol. 13, no. 10, pp. 1558–1568, 2004. View at Google Scholar · View at Scopus
  114. H. J. Thompson, J. N. McGinley, P. Wolfe, M. Singh, V. E. Steele, and G. J. Kelloff, “Temporal sequence of mammary intraductal proliferations, ductal carcinomas in situ and adenocarcinomas induced by 1-methyl-1-nitrosourea in rats,” Carcinogenesis, vol. 19, no. 12, pp. 2181–2185, 1998. View at Publisher · View at Google Scholar
  115. S. J. Santos, M. D. Aupperlee, J. Xie et al., “Progesterone receptor A-regulated gene expression in mammary organoid cultures,” Journal of Steroid Biochemistry and Molecular Biology, vol. 115, no. 3, pp. 161–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. A. McTiernan, C. Kooperberg, E. White et al., “Recreational Physical Activity and the Risk of Breast Cancer in Postmenopausal Women: The Women's Health Initiative Cohort Study,” Journal of the American Medical Association, vol. 290, no. 10, pp. 1331–1336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  117. G. Newman and R. R. Gonzalez-Perez, “Leptin-cytokine crosstalk in breast cancer,” Molecular and Cellular Endocrinology, vol. 382, no. 1, pp. 570–582, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. H. Shimizu, Y. Shimomura, Y. Nakanishi et al., “Estrogen increases in vivo leptin production in rats and human subjects,” Journal of Endocrinology, vol. 154, no. 2, pp. 285–292, 1997. View at Publisher · View at Google Scholar · View at Scopus
  119. H. Tan, L. Yi, N. S. Rote, W. W. Hurd, and S. Mesiano, “Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 5, pp. E719–E730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  120. Y. Xie, Y.-L. Wang, L. Yu et al., “Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells,” Journal of Steroid Biochemistry and Molecular Biology, vol. 126, no. 3, pp. 113–120, 2011. View at Publisher · View at Google Scholar · View at Scopus